From 2021, Professor Charlie C. Xue is an Associate Deputy Vice-Chancellor (International). He provides strategic and executive leadership in international activities in STEM education, research, professional, industry and community engagement.
Distinguished Professor Charlie C. Xue commenced his current role as Associate Deputy Vice Chancellor (International) in January 2021.
From 2011-2021, he successfully led the transformation of the School of Health Sciences (Head of School, 2011-2015) then RMIT Health and Biomedical Sciences (Executive Dean, 2016-2020). His strategic and executive leadership has resulted in significant growth of RMIT's reputation in health and biomedical education, biomedical and clinical research and strategic industry partnerships.
Professor Xue is a member of the College Executive and contributes to the strategic direction setting of the STEM College. He works collaboratively with other members of the wider College Executive for the planning and development of academic programs, cross-disciplinary research and business development/ commercial activities. Professor Xue is also Chair of the University's Cultural Inclusion Working Group which promotes diversity and inclusion in our academic community.
Over the last decade, Professor Xue has contributed to the RMIT University's Academic Board, Academic Promotion Review Panels and the Athena SWAN Committee to address the gender equality in the academic workforce.
Professor Xue also holds the following appointments:
- Member, Australian Health Practitioner Regulation Agency (Ahpra) Education Provider Reference Group [2021-]
- National Chair, Chinese Medicine Board of Australia, an appointment by the Australian Health Workforce Ministerial Council [2011- 2021]
- Member, World Health Organization (WHO) Expert Advisory Panel for Traditional Medicine (appointed by Director-General of the WHO, Geneva) [2007-]
- Director, WHO Collaborating Centre for Traditional Medicine, RMIT University [2005-]
- Member, Royal Society of Victoria [2017-]
Professor Xue's main research interests are evidence-based medicine and translational research with a focus on Complementary and Alternative Medicine (CAM, acupuncture and herbal medicine) for chronic respiratory diseases and pain management. His team consists of six postdoctoral fellows and a number of PhD candidates. He has established extensive research networks nationally and internationally. Professor Xue’s research has been supported by grants from the Australian National Health and Medical Research Council (NHMRC), Australian Research Council, Federal and State Government Grants, and international research collaboration grants.
Honours and awards
- Office of Learning and Teaching Citation (Team Leader), Australian Government, 2013
- RMIT Learning and Teaching Award (Team Leader), RMIT University, 2012
- Vice Chancellor Research Excellence Award, RMIT University, 2011
- Ralph McIntosh Medal, Council of RMIT University, May 2010
Research grant reviews and contribution to peer-reviewed journals
Professor Xue contributes to peer-review process for major grant funding schemes (including the NHMRC), journals as Advisory/Editorial Board Members and as a reviewer.
Industry and international consultancy
- Consultant/Chair/Advisor: for over 20 projects for the WHO [from 2002-]
- Honorary Advisor, Institute of Chinese Medicine, The Chinese University of Hong Kong, from August 2001-present
- Doctor of Philosophy, RMIT University, 2000, Australia
- Bachelor of Medicine, Guangzhou College of Chinese Medicine, 1987, China
- Coyle, M.,Liu, J.,Zhang, M.,Zhang, A.,Xue, C.,Yang, H.,Nie, G.,Guo, X.,Lu, C. (2021). Evidence-based Clinical Chinese Medicine - Volume 24: Menopause, World Scientific, Singapore
- Chen, Y.,Shergis, J.,Zhang, T.,Xue, C., et al, . (2021). Herbal Medicine for Adult Patients with Cough Variant Asthma: A Systematic Review and Meta-Analysis In: Evidence-based Complementary and Alternative Medicine, 2021, 1 - 13
- Guo, Q.,Chen, Q.,Xue, C.,Zhang, A.,Coyle, M. (2021). Chinese medicine syndromes and stages of early breast cancer: hierarchical cluster analysis and implication for clinical practice In: Journal of Alternative and Complementary Medicine, 27, 904 - 914
- Ling, J.,Olga, M.,Khunti, K.,Zhang, A.,Xue, C. (2021). Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care In: Diabetes, Obesity and Metabolism, 23, 1518 - 1531
- Coyle, M.,Liu, J.,Yang, H.,Wang, K.,Zhang, A.,Guo, X.,Lu, C.,Xue, C. (2021). Licorice (Glycyrrhiza spp.) and jujube (Ziziphus jujuba Mill.) formula for menopausal symptoms: Classical records, clinical evidence and experimental data In: Complementary Therapies in Clinical Practice, 44, 1 - 7
- He, Y.,Zhang, H.,Li, Y.,Long, S.,Xiao, S.,May, B.,Zhang, A.,Guo, X.,Xue, C.,Lu, C. (2021). Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial In: Acupunct Med., , 1 - 9
- Coyle, M.,Qin, X.,Zhang, M.,Wang, K.,Zhang, A.,Xue, C.,Lu, C.,Yang, L.,Liang, J.,Mao, W.,Guo, X.,Liu, X. (2020). Evidence-Based Clinical Chinese Medicine - Volume 22: Urinary Tract Infection, World Scientific Publishing Company, Singapore
- Cai, Y.,Zhang, C.,Zhang, T.,Da Costa, C.,Xue, C.,Zehuai, W. (2020). Electroacupuncture for Poststroke Spasticity: Results of a Pilot Pragmatic Randomized Controlled Trial In: Journal of Pain and Symptom Management, 61, 305 - 314
- Di, Y.,Lu, C.,Zhang, T.,Xue, C. (2020). Additional Benefit of Chinese Medicine Formulae Including Dioscoreae rhizome (Shanyao) for Diabetes Mellitus: Current State of Evidence In: Frontiers in Endocrinology, 11, 1 - 19
- Lyu, S.,Zhang, S.,Guo, X.,Zhang, A.,Sun, J.,Lu, C.,Xue, C.,Luo, X. (2020). Oral Chinese Herbal Medicine as Prophylactic Treatment for Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials In: Evidence-based Complementary and Alternative Medicine, 2020, 1 - 20
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 9. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2019 to 2020)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 7. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2017 to 2019)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 6. Funded by: Confucius Institute Headquarters Business Development Program Grant 2016 from (2016 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 5. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2015 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 4. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2014 to 2014)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stages 6. Funded by: Confucius Institute Headquarters Business Development Program Fund from (2016 -2017) - $220,000 [CIA]
- Evaluation of Traditional and Scientific Evidence of Chinese Medicine (Stage I, II and III projects), Guangdong Provincial Academy of Chinese Medical Sciences, 2008-2016, $3,050,000): [CIA]
- The China-Australia Research Centre for Chinese Medicine, 2013-2020, $2,400,000: CIA and Co-Director of the Centre
- Translational Medicine Projects at the China-Australia Research Centre for Chinese Medicine, 2016-2025, $8,229,113, CIA and Director of the Centre
11 PhD Current Supervisions36 PhD Completions and 9 Masters by Research Completions